Companies: 10,795·Total market cap: $144.5T
Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated

PRLDNASDAQHealthcare● Active
$3.99
+$0.15(+3.91%)
Market Cap$227161780
P/E Ratio
52W High$5.54
52W Low$0.75

Prelude Therapeutics Incorporated (PRLD) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PRLD · as of Mar 10, 2026

Latest filing snapshot

79
-52-39.69%vs prior year

Prelude Therapeutics Incorporated (PRLD) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
79
Change (1Y)
-52
Growth % (1Y)
-39.69%
Revenue / Employee
$153.7K
Net Income / Employee
$-1.26M
Market Cap
$219M

PRLD Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1079-52-39.69%
2025-03-10131+3+2.34%
2024-02-15128+6+4.92%
2023-03-15122+6+5.17%
2022-03-17116+48+70.59%
2021-03-1668

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Caribou Biosciences, Inc.
CRBU
Caribou Biosciences, Inc.
147
#2
Enanta Pharmaceuticals, Inc.
ENTA
Enanta Pharmaceuticals, Inc.
131
#3
Foghorn Therapeutics Inc.
FHTX
Foghorn Therapeutics Inc.
112
#4
Prelude Therapeutics Incorporated
PRLD
Prelude Therapeutics IncorporatedYOU
79
#5
Immuneering Corporation
IMRX
Immuneering Corporation
54
#6
Eupraxia Pharmaceuticals Inc.
EPRX
Eupraxia Pharmaceuticals Inc.
33
#7
Avalo Therapeutics, Inc.
AVTX
Avalo Therapeutics, Inc.
23
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PRLD peer comparison

About PRLD employees

PRLD Employees · Headcount

Prelude Therapeutics Incorporated (PRLD) employee data is sourced from the annual SEC 10-K filing. As of 2025, Prelude Therapeutics Incorporated had 79 full-time employees globally. Full-time employees only. Global consolidated headcount.

Prelude Therapeutics Incorporated employs 79 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $153,671, reflecting the company's operational efficiency.

Prelude Therapeutics Incorporated's workforce decreased by 52 (39.69%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Prelude Therapeutics Incorporated's revenue per employee of $153,671 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

PRLD Employees · 5 questions

As of the latest SEC 10-K filing (2025), Prelude Therapeutics Incorporated had 79 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Prelude Therapeutics Incorporated employee counthow many employees does Prelude Therapeutics Incorporated havePRLD total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-10